| scholarly article | Q13442814 |
| P2093 | author name string | X Wu | |
| A J Levine | |||
| J Lin | |||
| C Reichner | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene | Q24298218 | ||
| Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen | Q24308837 | ||
| Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals | Q24314293 | ||
| The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases | Q24319848 | ||
| Rapid and efficient site-specific mutagenesis without phenotypic selection | Q27860608 | ||
| A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle | Q28189224 | ||
| p21 is a universal inhibitor of cyclin kinases | Q28257305 | ||
| Physical interaction of the retinoblastoma protein with human D cyclins | Q28269103 | ||
| Cyclin D1 is a nuclear protein required for cell cycle progression in G1 | Q28269145 | ||
| Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution | Q28300442 | ||
| p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene | Q28300451 | ||
| A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen | Q28303106 | ||
| Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 | ||
| p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 | Q28505037 | ||
| Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation | Q28611416 | ||
| Induction of apoptosis in fibroblasts by c-myc protein | Q29614346 | ||
| Suppression of human colorectal carcinoma cell growth by wild-type p53 | Q29618318 | ||
| Regulation of retinoblastoma protein functions by ectopic expression of human cyclins | Q29618320 | ||
| Mammalian G1 cyclins | Q29618855 | ||
| Functional interactions of the retinoblastoma protein with mammalian D-type cyclins | Q29618856 | ||
| Wild-type p53 can inhibit oncogene-mediated focus formation | Q30450825 | ||
| Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. | Q34173355 | ||
| p53 functions as a cell cycle control protein in osteosarcomas | Q34254691 | ||
| Rearrangement of the p53 gene in human osteogenic sarcomas | Q34360802 | ||
| The p53 proto-oncogene can act as a suppressor of transformation | Q34440370 | ||
| p53 and E2F-1 cooperate to mediate apoptosis | Q35185411 | ||
| Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression | Q36551292 | ||
| The p53 tumour suppressor gene | Q37751892 | ||
| Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. | Q40805671 | ||
| The tumor suppression function of p21Waf is contained in its N-terminal half ('half-WAF'). | Q41324287 | ||
| Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. | Q41358760 | ||
| p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells | Q41368682 | ||
| Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase | Q41368684 | ||
| Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. | Q41368691 | ||
| Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. | Q41436520 | ||
| Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein | Q41696617 | ||
| Presence of a potent transcription activating sequence in the p53 protein | Q41724404 | ||
| FAR1 links the signal transduction pathway to the cell cycle machinery in yeast. | Q45944819 | ||
| p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. | Q45993768 | ||
| Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen | Q48084448 | ||
| Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. | Q53505779 | ||
| Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 | Q59063779 | ||
| p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features | Q67841746 | ||
| p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage | Q72297293 | ||
| Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor | Q72320119 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1786-1793 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Analysis of wild-type and mutant p21WAF-1 gene activities | |
| P478 | volume | 16 |
| Q38797735 | A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin |
| Q33948911 | Analysis of individual molecular events of DNA damage response by flow- and image-assisted cytometry |
| Q40796704 | Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression |
| Q74164931 | Ankyrin for clues about the function of p16INK4a |
| Q53569604 | Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways. |
| Q28533417 | CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point |
| Q34981345 | CDKs and CKIs: molecular targets for tissue remodelling |
| Q41345498 | CDKs and cyclins in transition(s). |
| Q47629898 | CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene |
| Q39037303 | CEP55 contributes to human gastric carcinoma by regulating cell proliferation |
| Q71985306 | Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1 |
| Q44557874 | Constitutive cytoplasmic localization of p21(Waf1/Cip1) affects the apoptotic process in monocytic leukaemia. |
| Q73023858 | Control of E2F activity by p21Waf1/Cip1 |
| Q77932294 | Coordinated changes in cell cycle machinery occur during keratinocyte terminal differentiation |
| Q42060468 | Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression |
| Q24336704 | Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex |
| Q24316125 | Cyclin-binding motifs are essential for the function of p21CIP1 |
| Q36799242 | Cyclin-dependent kinase inhibitor p20 controls circadian cell-cycle timing. |
| Q33774973 | Cyclin-dependent kinase inhibitor p21 modulates the DNA primer-template recognition complex |
| Q28393323 | DNA damage response induced by tobacco smoke in normal human bronchial epithelial and A549 pulmonary adenocarcinoma cells assessed by laser scanning cytometry |
| Q26822413 | DNA damage signaling assessed in individual cells in relation to the cell cycle phase and induction of apoptosis |
| Q40894496 | Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity |
| Q33778594 | Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor |
| Q36569390 | Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution |
| Q38321059 | Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression |
| Q46354780 | Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor |
| Q36848888 | Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer |
| Q28583336 | Global identification of genes related to nutrient deficiency in intervertebral disc cells in an experimental nutrient deprivation model |
| Q42812297 | Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway |
| Q77845951 | Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway |
| Q41079253 | Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. |
| Q36907227 | Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities |
| Q39259475 | Human papillomavirus 18 E1^E4 protein interacts with cyclin A/CDK 2 through an RXL motif |
| Q40020347 | Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors |
| Q37439146 | Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy |
| Q39444837 | Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes |
| Q40643325 | Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). |
| Q34742793 | Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein |
| Q48243475 | Interplay between p53 and Ink4c in spermatogenesis and fertility. |
| Q41193883 | JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21. |
| Q45757774 | Lack of mutation in the WAF1/CIP1 gene during bovine leukemia virus-induced leukemogenesis |
| Q36255453 | OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. |
| Q40790669 | P21(Cip1) induced by Raf is associated with increased Cdk4 activity in hematopoietic cells. |
| Q35033462 | P21Waf1 control of epithelial cell cycle and cell fate |
| Q28189989 | Phosphorylation of the CCAAT displacement protein (CDP)/Cux transcription factor by cyclin A-Cdk1 modulates its DNA binding activity in G(2) |
| Q39454436 | Poly(A) polymerase phosphorylation is dependent on novel interactions with cyclins |
| Q24670485 | Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis |
| Q39543452 | Rapid purification of protein complexes from mammalian cells |
| Q40243606 | Requirement for pre-existing of p21 to prevent doxorubicin-induced apoptosis through inhibition of caspase-3 activation |
| Q42055057 | Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding |
| Q35141843 | Role of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation and Fibrosis |
| Q24646032 | Specific regulation of E2F family members by cyclin-dependent kinases |
| Q34076012 | Strategies for manipulating the p53 pathway in the treatment of human cancer. |
| Q37469268 | Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. |
| Q40967344 | The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts |
| Q39085673 | Transcriptional repression of Bmp2 by p21(Waf1/Cip1) links quiescence to neural stem cell maintenance |
| Q64890070 | Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer. |
| Q28647314 | p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity |
| Q40022880 | p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases |
| Q37217826 | p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. |
Search more.